BPC-157 is in this group today but it is the group that is actively moving
Who are B12 injections typically for
For Zepbound, singleuse vials pose safety risks if reused
Marc Jean-Gilles, DO, FACOG , offers personalized advice, ensuring each patient receives the most appropriate treatment tailored to their needs
No, lymph node swelling (lymphadenopathy) is not listed as a recognized adverse effect in FDA-approved prescribing information for tirzepatide (Mounjaro or Zepbound) and was not identified in pivotal clinical trials
FDAs concerns with unapproved GLP-1 drugs used for weight loss, United States Food and Drug Administration (2024) FDA approves first oral GLP-1 treatment for Type 2 diabetes, United States Food and Drug Administration (2019) Semaglutide for Type 2 diabetes, CADTH Health Technology Review (2023) Anti-inflammatory benefits of semaglutide: State of the art, Journal of Clinical & Translational Endocrinology (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice